Name | Sector | Analyst Name | Analyst Job Title | Star Rating | Date | |
---|---|---|---|---|---|---|
Gilead Sciences Inc | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
GSK PLC | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
GSK PLC ADR | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Johnson & Johnson | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Merck & Co Inc | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Moderna Inc | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Novartis AG ADR | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Novartis AG Registered Shares | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Novo Nordisk AS ADR | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Novo Nordisk AS Class B | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Pfizer Inc | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Regeneron Pharmaceuticals Inc | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Roche Holding AG | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Roche Holding AG ADR | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Sanofi SA | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Sanofi SA ADR | Healthcare | Karen Andersen | Strategist | 18/11/2024 | ||
Stifel Financial Corp | Financial Services | Michael Wong | Director | 18/11/2024 | ||
Morgan Stanley | Financial Services | Michael Wong | Director | 18/11/2024 | ||
Clinuvel Pharmaceuticals Ltd | Healthcare | Shane Ponraj | Equity Analyst | 18/11/2024 | ||
Regis Healthcare Ltd | Healthcare | Shane Ponraj | Equity Analyst | 18/11/2024 |